These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 32387053

  • 1. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
    Zhao J, Feng ZX, Wei M, Liu G, Solarte CE, Li B, Wang Y, Zhang C, Gallie BL.
    Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
    Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW.
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
    Ye H, Du Y, Chen R, Luo X, Mao Y, Ai S, Ma W, Ding Y, Li Q, Yang H.
    Curr Eye Res; 2016 Nov; 41(11):1507-1512. PubMed ID: 27158739
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retrospective analysis of primarily treated group D retinoblastoma.
    Kiratli H, Koç İ, Inam O, Varan A, Akyüz C.
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
    [Abstract] [Full Text] [Related]

  • 8. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
    Yannuzzi NA, Francis JH, Marr BP, Belinsky I, Dunkel IJ, Gobin YP, Abramson DH.
    JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
    [Abstract] [Full Text] [Related]

  • 9. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
    Zhou C, Wen X, Ding Y, Ding J, Jin M, Liu Z, Wang S, Han M, Yuan H, Xiao Y, Wu L, Wang J, Li Y, Yu J, Wen Y, Ye J, Liu R, Chen Z, Xue S, Lu W, Liao H, Cui J, Zhu D, Lu F, Tang S, Wu Y, Yangkyi T, Zhang G, Wubuli M, Guo H, Wang X, He Y, Sheng X, Wang Q, Luo Y, Fan J, Qi J, Yu Z, Tan J, Liang J, Sun X, Jin L, Yang X, Zhang J, Ji X, Zhao J, Jia R, Fan X.
    Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
    [Abstract] [Full Text] [Related]

  • 10. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [Abstract] [Full Text] [Related]

  • 11. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [Abstract] [Full Text] [Related]

  • 12. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 13. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
    Kletke SN, Feng ZX, Hazrati LN, Gallie BL, Soliman SE.
    Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
    [Abstract] [Full Text] [Related]

  • 14. Globe salvage treatment in group D and group E retinoblastoma.
    Hussain AK, Rahul RA, Carlos RL, Francisco ZM, María GL, Flavia P, Chiara B, Davide B.
    Rom J Ophthalmol; 2021 Sep; 65(1):20-24. PubMed ID: 33817429
    [Abstract] [Full Text] [Related]

  • 15. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A.
    Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
    [Abstract] [Full Text] [Related]

  • 16. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
    Fabian ID, Stacey AW, Chowdhury T, Duncan C, Karaa EK, Scheimberg I, Reddy MA, Sagoo MS.
    Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
    [Abstract] [Full Text] [Related]

  • 17. Management and outcome of unilateral retinoblastoma.
    Mallipatna AC, Sutherland JE, Gallie BL, Chan H, Héon E.
    J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
    [Abstract] [Full Text] [Related]

  • 18. Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma.
    Soliman SE, Dimaras H, Souka AA, Ashry MH, Gallie BL.
    J Fr Ophtalmol; 2015 Jun; 38(6):550-8. PubMed ID: 25982424
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
    Berry JL, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, Lee TC, Murphree AL.
    Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170
    [Abstract] [Full Text] [Related]

  • 20. Tumour size criteria for Group D and E eyes in the International Classification System for Retinoblastoma: effects on rates of globe salvage and high-risk histopathologic features.
    Kim JW, Shah SN, Green S, O'Fee J, Tamrazi B, Berry JL.
    Acta Ophthalmol; 2020 Feb; 98(1):e121-e125. PubMed ID: 31421017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.